Nassif Martina, Abdelghani Mohammad, Bouma Berto J, Straver Bart, Blom Nico A, Koch Karel T, Tijssen Jan G P, Mulder Barbara J M, de Winter Robbert J
a Department of Cardiology, Academic Medical Center , University of Amsterdam , Amsterdam , The Netherlands.
b Department of Pediatric Cardiology, Academic Medical Center , University of Amsterdam , Amsterdam , The Netherlands.
Expert Rev Med Devices. 2016 Jun;13(6):555-68. doi: 10.1080/17434440.2016.1182860. Epub 2016 May 11.
Since King and Mills' pioneering work in percutaneous closure devices of secundum atrial septal defects (ASD) four decades ago, developments in device shape, material and implantation technique led to adoption of percutaneous ASD closure as current treatment of choice. Not only was the feasibility of such a percutaneous procedure tested altogether, but pursuing the ideal device in terms of safety and efficacy became priority.
In this review we present the historical development of ASD devices in design, material and technique with clinical data, and provide the future perspectives in percutaneous ASD closures.
An 'ideal device' requires complete defect closure with negligible risk of complications using a safe, straightforward delivery technique with repositioning and retrieving properties. Some of the devices currently at hand come close to fulfilling these criteria, however none seem to provide those prerequisites completely. By understanding how challenges in device development were overcome in the past, new insights into future improvements are given.
自40年前金和米尔斯在房间隔缺损(ASD)经皮封堵装置方面开展开创性工作以来,装置形状、材料和植入技术的发展促使经皮ASD封堵术成为当前的首选治疗方法。人们不仅全面测试了这种经皮手术的可行性,而且在安全性和有效性方面追求理想的装置成为了首要任务。
在本综述中,我们介绍了ASD装置在设计、材料和技术方面的历史发展以及临床数据,并提供了经皮ASD封堵术的未来展望。
一个“理想的装置”需要使用安全、直接的输送技术,具备重新定位和回收功能,以完全闭合缺损且并发症风险可忽略不计。目前手头的一些装置接近满足这些标准,但似乎没有一个能完全提供这些先决条件。通过了解过去如何克服装置开发中的挑战,为未来的改进提供了新的见解。